AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy

RH Falk, KM Alexander, R Liao, S Dorbala - Journal of the American …, 2016 - jacc.org
The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …

Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment

OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018 - Elsevier
The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …

Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy

E Muchtar, LA Blauwet, MA Gertz - Circulation research, 2017 - Am Heart Assoc
Restrictive cardiomyopathy (RCM) is characterized by nondilated left or right ventricle with
diastolic dysfunction. The restrictive cardiomyopathies are a heterogenous group of …

Diagnosis, prognosis, and therapy of transthyretin amyloidosis

MA Gertz, MD Benson, PJ Dyck, M Grogan… - Journal of the American …, 2015 - jacc.org
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive
neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant …

Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis

AV Kristen, S Ajroud-Driss, I Conceição… - Neurodegenerative …, 2019 - Taylor & Francis
Hereditary transthyretin-mediated amyloidosis is a rapidly progressive, heterogeneous
disease caused by the accumulation of misfolded transthyretin protein as amyloid fibrils at …

[HTML][HTML] Guideline of transthyretin-related hereditary amyloidosis for clinicians

Y Ando, T Coelho, JL Berk, MW Cruz… - Orphanet journal of rare …, 2013 - Springer
Transthyretin amyloidosis is a progressive and eventually fatal disease primarily
characterized by sensory, motor, and autonomic neuropathy and/or cardiomyopathy. Given …

Transthyretin (TTR) cardiac amyloidosis

FL Ruberg, JL Berk - Circulation, 2012 - Am Heart Assoc
The systemic amyloidoses are a family of diseases induced by misfolded or misassembled
proteins. Extracellular deposition of these proteins as soluble or insoluble cross-sheets …

[PDF][PDF] Cardiac amyloidosis: an update on diagnosis and treatment

JP Donnelly, M Hanna - Cleve Clin J Med, 2017 - cdn.mdedge.com
Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due
to enhanced clinical awareness and better diagnostic imaging. CA is becoming of …

Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis

A Carroll, PJ Dyck, M de Carvalho… - Journal of Neurology …, 2022 - jnnp.bmj.com
Hereditary transthyretin amyloidosis (ATTRv) is a severe, adult-onset autosomal dominant
inherited systemic disease predominantly affecting the peripheral and autonomic nervous …

[HTML][HTML] First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

D Adams, OB Suhr, E Hund, L Obici… - Current opinion in …, 2016 - journals.lww.com
This review summarizes the findings from two meetings of the European Network for TTR-
FAP (ATTReuNET). This is an emerging group comprising representatives from 10 …